Abbott receives FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform 28 April
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 25 April
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test 17 April
